The Motley Fool Previous Page

1 Health Care Company Launching Now

Keith Speights
October 10, 2012

There should be a new product on the shelves the next time you're in the health and beauty aids section of your favorite store. OraSure Technologies (Nasdaq: OSUR  ) hit the retail market nationwide on Wednesday with its in-home HIV test.

The company's OraQuick test is the first rapid infectious disease test to be sold directly to customers for in-home use. The FDA approved the test, which detects HIV antibodies with an oral swab, as an over-the-counter product in July.

Launch time
OraSure shares shot up around 5% in intraday trading on the news about OraQuick's retail availability. However, the stock still needs to climb another 30% to reach its highs made following the FDA approval in July.

Of course, retail availability doesn't necessarily translate to retail saleability. OraSure appears to be making the right moves to improve the likelihood of success, though. 

OraSure went big with the launch, securing relationships with major players including CVS Caremark (NYSE: CVS  ) ,  Rite Aid  (NYSE: